Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.wallstreet-online.de › nachricht › 18250736-mirum-pharmaceuticals-livmarliMirum Pharmaceuticals’ LIVMARLI Approved in the European Union...

    Hace 1 día · Significant improvements were also observed in total bilirubin and growth versus placebo. The most common treatment emergent adverse event was diarrhea, which was predominantly mild, ...

  2. www.ansa.it › sito › notizieMirum Pharmaceuticals’ LIVMARLI Approved in the ... - Agenzia...

    Hace 1 día · Significant improvements were also observed in total bilirubin and growth versus placebo. The most common treatment emergent adverse event was diarrhea, which was predominantly mild, ...

  3. www.koreabiomed.com › news › articleViewLG Chem's immuno-oncology drug wins domestic phase 1 approval

    Hace 1 día · The primary endpoints are the number of participants with dose-limiting toxicities (DLTs) and the incidence of treatment-emergent adverse events. The secondary endpoints are overall response rate (ORR), progression-free survival (PFS), and overall survival (OS).

  4. uk.marketscreener.com › quote › stockMirum Pharmaceuticals, Inc.' LIVMARLI Approves in the European...

    Hace 1 día · Mirum Pharmaceuticals, Inc. announced that the European Commission has granted marketing authorization for LIVMARLI® oral solution for the treatment of progressive familial intrahepatic cholestasis ...

  5. in.marketscreener.com › quote › stockMirum Pharmaceuticals’ LIVMARLI Approved in the European Union...

    Hace 13 horas · European Commission grants LIVMARLI marketing authorization for treatment of PFIC in patients three months and older. Approval follows positive opinion from CHMP concluding LIVMARLI’s clinical...

  6. www.finanznachrichten.de › nachrichten-2024-07 › 62678259-tonix-pharmaceuticalsTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals...

    Hace 1 día · In both pivotal studies, the most common treatment-emergent adverse event was tongue or mouth numbness at the administration site, which was temporally related to dosing, self-limited, never rated ...

  7. in.marketscreener.com › quote › stockTonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with...

    Hace 14 horas · c25bacb9ab59c80c177cf81.Fk2_uDRWL4zD2eAHyJhy0vhUMOUQxjunS_qeAzC3kbM.LifG72M0Y-2Q6bJ0ivQBu74taYAj8Q3-c5CrRm_Q1NlQBY2OeQNh-4D0tQ